semaglutide injection weight loss FDA approves obesity drug that

It is FDA approved for weight management and to reduce the risk of stroke, heart attack, or other cardiovascular death in people who are overweight or have obesity

Childhood obesity: Increased risk for cardiometabolic disease and cancer in adulthood

This scientific breakthrough made Wegovy one of the most significant pharmaceutical launches in metabolic health within the past 20 years

But does this automatically mean better results

Even a 12-14 hour overnight fasting window may help improve how responsive your body is to the GLP-1 it produces, says Jean-Marc

On the other hand, the most common symptom associated with GLP-1 RAs is gastrointestinal symptoms, mainly nausea